Abstracts tagged "outcome measures and rituximab"

Abstract Number: 206 • ACR/ARHP Annual Meeting 2012

Clinical, Laboratory, and Cellular Responses in the Rituximab in Myositis Trial in Patients Enrolled At the National Institutes of Health

Lisa G. Rider¹, Adrienne L. Yip², Iren Horkayne-Szakaly³, Rita Volochayev², Joseph A. Shrader⁴, Maria L. Turner⁵, Heidi H. Kong⁵, Minal S. Jain⁴, Anna V. Jansen¹, Chester V. Oddis⁶, Thomas A. Fleisher⁷ and Frederick W. Miller¹, ¹Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, ²National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, ³Joint Pathology Center, Silver Spring, MD, ⁴Rehabilitation Medicine, Rehab Medicine, NIH Clinical Center, Bethesda, MD, ⁵Dermatology Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, ⁶Rheum/Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁷Laboratory Medicine, Laboratory Medicine, NIH Clinical Center, Bethesda, MD